These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 24659876)

  • 1. Individualization of chronic hepatitis C treatment according to the host characteristics.
    Gatselis NK; Zachou K; Saitis A; Samara M; Dalekos GN
    World J Gastroenterol; 2014 Mar; 20(11):2839-53. PubMed ID: 24659876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.
    Lee TH; Tillmann HL; Patel K
    Mol Diagn Ther; 2014 Feb; 18(1):25-38. PubMed ID: 24022240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices.
    Di Marco V; Calvaruso V; Grimaudo S; Ferraro D; Pipitone RM; Di Stefano R; Craxì A
    J Viral Hepat; 2013 Feb; 20(2):113-21. PubMed ID: 23301546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphisms as predictors of response to antiviral treatment in chronic hepatitis C virus infection].
    Pár A
    Orv Hetil; 2011 May; 152(22):876-81. PubMed ID: 21565755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection.
    Cariani E; Villa E; Rota C; Critelli R; Trenti T
    Clin Chem Lab Med; 2011 Aug; 49(8):1247-1256. PubMed ID: 21612542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic variation-guided management in chronic hepatitis C.
    Hsu CS; Kao JH
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):497-506. PubMed ID: 22928901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of IL28B for chronic hepatitis C treatment toward personalized medicine.
    Matsuura K; Watanabe T; Tanaka Y
    J Gastroenterol Hepatol; 2014 Feb; 29(2):241-9. PubMed ID: 24325405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genome-wide association study on and the clinical application to chronic hepatitis C].
    Sugiyama M; Mizokami M
    Uirusu; 2011 Jun; 61(1):15-24. PubMed ID: 21972552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?
    Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH
    World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C.
    Takahashi H; Mizuta T; Oeda S; Isoda H; Nakashita S; Kawaguchi Y; Izumi N; Hirai M; Kurose K; Iwane S; Eguchi Y; Kimura S; Anzai K; Ozaki I
    J Viral Hepat; 2013 Apr; 20(4):e124-6. PubMed ID: 23490380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Interferons in Chronic Hepatitis C Infection.
    Scagnolari C; Monteleone K; Cacciotti G; Antonelli G
    Curr Drug Targets; 2017; 18(7):844-850. PubMed ID: 26844564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.
    Aghemo A; Colombo M
    Semin Immunopathol; 2013 Jan; 35(1):111-20. PubMed ID: 23010890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between inosine triphosphate genotype and outcome of extended therapy in hepatitis C virus patients with a late viral response to pegylated-interferon and ribavirin.
    Hai H; Tamori A; Enomoto M; Morikawa H; Uchida-Kobayashi S; Fujii H; Hagihara A; Kawamura E; Thuy le TT; Tanaka Y; Kawada N
    J Gastroenterol Hepatol; 2014 Jan; 29(1):201-7. PubMed ID: 23980585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.
    Seto WK; Tsang OT; Liu K; Chan JM; Wong DK; Fung J; Lai CL; Yuen MF
    J Viral Hepat; 2013 Jul; 20(7):470-7. PubMed ID: 23730840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetics and hepatitis C treatment: towards a personalized treatment?].
    Lens García S; Coto-Llerena M; Pérez del Pulgar Gallart S; Forns Bernhardt X
    Gastroenterol Hepatol; 2011 May; 34(5):352-60. PubMed ID: 21420759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PROGNOSTIC VALUE OF THE COMBINATION OF BLOOD GROUP SPECIFICITY AND INTERLEUKIN 28B GENE POLYMORPHISM FOR ESTIMATION OF EFFICIENCY OF THERAPY WITH THE USE OF PEGYLATED INTERFERON α-2 AND RIBAVARIN IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C].
    Ogurtsov PP; Kukhareva EI
    Klin Med (Mosk); 2016; 94(3):224-30. PubMed ID: 27522730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.
    Ahlenstiel G; Booth DR; George J
    J Gastroenterol; 2010 Sep; 45(9):903-10. PubMed ID: 20635099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopenia.
    Ogawa E; Furusyo N; Murata M; Ikezaki H; Ihara T; Hayashi T; Toyoda K; Okada K; Kainuma M; Kajiwara E; Takahashi K; Satoh T; Hayashi J
    J Viral Hepat; 2013 Dec; 20(12):838-46. PubMed ID: 24304453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy.
    Khan AJ; Saraswat VA; Ranjan P; Parmar D; Negi TS; Mohindra S
    J Med Virol; 2019 Apr; 91(4):659-667. PubMed ID: 30431653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of human gene polymorphisms on HCV infection and disease outcome.
    Schaefer EA; Chung RT
    Semin Liver Dis; 2011 Nov; 31(4):375-86. PubMed ID: 22189977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.